SCHEMBL6665978

SCHEMBL6665978

O=C(O)c1c[n+](=O)[nH]c2ccccc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 2/20 0.49
CFTR P13569 3/20 0.42
PARP1 P09874 1/20 0.42
MAOB P27338 1/20 0.41
KDM4E B2RXH2 4/20 0.41
CSNK2A2 P19784 1/20 0.41
CSNK2B P67870 1/20 0.41
CSNK2A1 P68400 1/20 0.41
GABRA1 P14867 1/20 0.40
GABRB2 P47870 1/20 0.40
ALDH1A1 P00352 2/20 0.40
GLA P06280 2/20 0.40
GAA P10253 2/20 0.40
HPGD P15428 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL377150 0.73 CFTR (0.67) PBRM1CFTRKDM4ECSNK2A2CSNK2B
SCHEMBL29551347 0.73 CFTR (0.67) PBRM1CFTRKDM4ECSNK2A2CSNK2B
Hydrochloric Acid SCHEMBL29766716 0.71 CFTR (0.65) PBRM1CFTRKDM4ECSNK2A2CSNK2B
Hydrochloric Acid SCHEMBL9046989 0.71 CFTR (0.65) PBRM1CFTRKDM4ECSNK2A2CSNK2B
Hydrochloric Acid SCHEMBL30585295 0.71 CFTR (0.65) PBRM1CFTRKDM4ECSNK2A2CSNK2B
SCHEMBL6629595 0.69 CFTR (0.61) PBRM1CFTRKDM4ECSNK2A2CSNK2B
Pyrazine SCHEMBL10716045 0.67 CFTR (0.58) PBRM1CFTRKDM4ECSNK2A2CSNK2B
SCHEMBL10526864 0.66 PBRM1 (0.67) PBRM1PARP1KDM4EALDH1A1GLA
SCHEMBL4943278 0.66 PBRM1 (1.00) PBRM1PARP1KDM4EALDH1A1GLA
SCHEMBL2241035 0.65 GAA (0.40) PARP1KDM4EALDH1A1GLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1443937-A1 SUBSTITUTED 1,4-BENZODIAZEPINES AND USES THEREOF FOR THE TREATMENT OF CANCER 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2004-08-11 EP disclosed
WO-2003041715-A1 SUBSTITUTED 1,4-BENZODIAZEPINES AND USES THEREOF FOR THE TREATMENT OF CANCER 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-05-22 WO disclosed